A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line

Molecular Cancer

Volumn 11, Issue , 2012, Pages

  Souissi, Inès ^a,b   Ladam, Patrick ^b,e   Cognet, Jean A H ^f   Le Coquil, Stéphanie ^a,b   Varin Blank, Nadine ^a,b   Baran Marszak, Fanny ^a,b,c   Metelev, Valeri ^d   Fagard, Remi ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c AVICENNE HOSPITAL   (France)

^d MOSCOW STATE UNIVERSITY   (Russian Federation)

^e UMR 7244   (France)

^f SORBONNE UNIVERSITÉ   (France)

Author keywords

Colon carcinoma cell line; Hairpin decoy oligodeoxynucleotide (hpdODN); STAT1; STAT3

Indexed keywords

ACTIN; CYCLIN D1; GAMMA INTERFERON; HAIRPIN DECOY OLIGODEOXYNUCLEOTIDE; INTERFERON REGULATORY FACTOR 1; OLIGODEOXYNUCLEOTIDE; STAT1 PROTEIN; STAT3 PROTEIN; TUBULIN; UNCLASSIFIED DRUG; OLIGODEOXYRIBONUCLEOTIDE;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; COLON CARCINOMA; CONTROLLED STUDY; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

CELL DEATH; CELL LINE, TUMOR; HUMANS; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHORYLATION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR;

EID: 84858230349     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-11-12     Document Type: Article

References (62)

1. Schindler C, Levy DE, Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem 2007, 282(28):20059-20063. 10.1074/jbc.R700016200, 17502367.
2. Qing Y, Stark GR. Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J Biol Chem 2004, 279(40):41679-41685. 10.1074/jbc.M406413200, 15284232.
3. Santos CI, Costa-Pereira AP. Signal transducers and activators of transcription-from cytokine signalling to cancer biology. Biochim Biophys Acta 2011, 1816(1):38-49.
4. Frank DA. STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett 2007, 251(2):199-210. 10.1016/j.canlet.2006.10.017, 17129668.
5. Jarnicki A, Putoczki T, Ernst M. Stat3: linking inflammation to epithelial cancer-more than a "gut" feeling?. Cell Div 2010, 5:14. 2887830, 20478049.
6. Bromberg JF. Activation of STAT proteins and growth control. Bioessays 2001, 23(2):161-169. 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0, 11169589.
7. Bromberg J. Stat proteins and oncogenesis. J Clin Invest 2002, 109(9):1139-1142. 150969, 11994401.
8. Al Zaid Siddiquee K, Turkson J. STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res 2008, 18(2):254-267. 10.1038/cr.2008.18, 2610254, 18227858.
9. de la Iglesia N, Konopka G, Puram SV, Chan JA, Bachoo RM, You MJ, Levy DE, Depinho RA, Bonni A. Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev 2008, 22(4):449-462. 10.1101/gad.1606508, 2238667, 18258752.
10. de la Iglesia N, Konopka G, Lim KL, Nutt CL, Bromberg JF, Frank DA, Mischel PS, Louis DN, Bonni A. Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. J Neurosci 2008, 28(23):5870-5878. 10.1523/JNEUROSCI.5385-07.2008, 2700037, 18524891.
11. Stephanou A, Latchman DS. STAT-1: a novel regulator of apoptosis. Int J Exp Pathol 2003, 84(6):239-244. 2517573, 14748743.
12. Najjar I, Fagard R. STAT1 and pathogens, not a friendly relationship. Biochimie 2010, 92:425-444. 10.1016/j.biochi.2010.02.009, 20159032.
13. Lin J, Buettner R, Yuan YC, Yip R, Horne D, Jove R, Vaidehi N. Molecular dynamics simulations of the conformational changes in signal transducers and activators of transcription, Stat1 and Stat3. J Mol Graph Model 2009, 28(4):347-356. 10.1016/j.jmgm.2009.08.013, 19781967.
14. Kramer OH, Heinzel T. Phosphorylation-acetylation switch in the regulation of STAT1 signaling. Mol Cell Endocrinol 2010, 315(1-2):40-48. 10.1016/j.mce.2009.10.007, 19879327.
15. Kovacic B, Stoiber D, Moriggl R, Weisz E, Ott RG, Kreibich R, Levy DE, Beug H, Freissmuth M, Sexl V. STAT1 acts as a tumor promoter for leukemia development. Cancer Cell 2006, 10(1):77-87. 10.1016/j.ccr.2006.05.025, 16843267.
16. Page BD, Ball DP, Gunning PT. Signal transducer and activator of transcription 3 inhibitors: a patent review. Expert Opin Ther Pat 2011, 27(6):e293-300.
17. Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C, Dey S, Sung B. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. Ann N Y Acad Sci 2009, 1171:59-76. 10.1111/j.1749-6632.2009.04911.x, 3141289, 19723038.
18. Yue P, Turkson J. Targeting STAT3 in cancer: how successful are we?. Expert Opin Investig Drugs 2009, 18(1):45-56. 10.1517/13543780802565791, 2610472, 19053881.
19. Schust J, Sperl B, Hollis A, Mayer TU, Berg T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 2006, 13(11):1235-1242. 10.1016/j.chembiol.2006.09.018, 17114005.
20. Miyoshi K, Takaishi M, Nakajima K, Ikeda M, Kanda T, Tarutani M, Iiyama T, Asao N, DiGiovanni J, Sano S. Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor. J Invest Dermatol 2011, 131(1):108-117. 10.1038/jid.2010.255, 20811392.
21. Leong PL, Andrews GA, Johnson DE, Dyer KF, Xi S, Mai JC, Robbins PD, Gadiparthi S, Burke NA, Watkins SF, et al. Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. Proc Natl Acad Sci USA 2003, 100(7):4138-4143. 10.1073/pnas.0534764100, 153061, 12640143.
22. Tadlaoui Hbibi A, Laguillier C, Souissi I, Lesage D, Le Coquil S, Cao A, Metelev V, Baran-Marszak F, Fagard R. Efficient killing of SW480 colon carcinoma cells by a STAT3 hairpin decoy oligodeoxynucleotide. Interference with interferon gamma-STAT1-mediated killing. FEBS Journal 2009, 276:2505-2515.
23. Souissi I, Najjar I, Ah-Koon L, Schischmanoff PO, Lesage D, Le Coquil S, Roger C, Dusanter-Fourt I, Varin-Blank N, Cao A, et al. A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-kappaB. BMC Cell Biol 2011, 12:14. 10.1186/1471-2121-12-14, 3082224, 21486470.
24. Kumar A, Commane M, Flickinger TW, Horvath CM, Stark GR. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 1997, 278(5343):1630-1632. 10.1126/science.278.5343.1630, 9374464.
25. Thomas M, Finnegan CE, Rogers KM, Purcell JW, Trimble A, Johnston PG, Boland MP. STAT1: a modulator of chemotherapy-induced apoptosis. Cancer Res 2004, 64(22):8357-8364. 10.1158/0008-5472.CAN-04-1864, 15548705.
26. Schindler C. STATs as activators of apoptosis. Trends Cell Biol 1998, 8(3):97-98. 10.1016/S0962-8924(98)01233-1, 9695817.
27. Sironi JJ, Ouchi T. STAT1-induced apoptosis is mediated by caspases 2, 3, and 7. J Biol Chem 2004, 279(6):4066-4074.
28. Townsend PA, Scarabelli TM, Davidson SM, Knight RA, Latchman DS, Stephanou A. STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J Biol Chem 2004, 279(7):5811-5820.
29. Baran-Marszak F, Feuillard J, Najjar I, Le Clorennec C, Bechet JM, Dusanter-Fourt I, Bornkamm GW, Raphael M, Fagard R. Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells. Blood 2004, 104(8):2475-2483. 10.1182/blood-2003-10-3508, 15217838.
30. Wall L, Burke F, Barton C, Smyth J, Balkwill F. IFN-gamma induces apoptosis in ovarian cancer cells in vivo and in vitro. Clin Cancer Res 2003, 9(7):2487-2496.
31. Labeur M, Refojo D, Wolfel B, Stalla J, Vargas V, Theodoropoulou M, Buchfelder M, Paez-Pereda M, Arzt E, Stalla GK. Interferon-gamma inhibits cellular proliferation and ACTH production in corticotroph tumor cells through a novel janus kinases-signal transducer and activator of transcription 1/nuclear factor-kappa B inhibitory signaling pathway. J Endocrinol 2008, 199(2):177-189. 10.1677/JOE-08-0011, 18715881.
32. Ning Y, Riggins RB, Mulla JE, Chung H, Zwart A, Clarke R. IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis. Mol Cancer Ther 2010, 9(5):1274-1285. 10.1158/1535-7163.MCT-09-1169, 2925293, 20457620.
33. Darnell JE, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264(5164):1415-1421. 10.1126/science.8197455, 8197455.
34. Wagner BJ, Hayes TE, Hoban CJ, Cochran BH. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J 1990, 9(13):4477-4484. 552240, 2176154.
35. de Koning JP, Dong F, Smith L, Schelen AM, Barge RM, van der Plas DC, Hoefsloot LH, Lowenberg B, Touw IP. The membrane-distal cytoplasmic region of human granulocyte colony-stimulating factor receptor is required for STAT3 but not STAT1 homodimer formation. Blood 1996, 87(4):1335-1342.
36. Horvath CM, Wen Z, Darnell JE. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev 1995, 9(8):984-994. 10.1101/gad.9.8.984, 7774815.
37. Seidel HM, Milocco LH, Lamb P, Darnell JE, Stein RB, Rosen J. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci USA 1995, 92(7):3041-3045. 10.1073/pnas.92.7.3041, 42355, 7708771.
38. Lamb P, Seidel HM, Haslam J, Milocco L, Kessler LV, Stein RB, Rosen J. STAT protein complexes activated by interferon-gamma and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties. Nucleic Acids Res 1995, 23(16):3283-3289. 10.1093/nar/23.16.3283, 307189, 7667105.
39. Ehret GB, Reichenbach P, Schindler U, Horvath CM, Fritz S, Nabholz M, Bucher P. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J Biol Chem 2001, 276(9):6675-6688. 10.1074/jbc.M001748200, 11053426.
40. Leung TH, Hoffmann A, Baltimore D. One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. Cell 2004, 118(4):453-464. 10.1016/j.cell.2004.08.007, 15315758.
41. Nelson HC, Finch JT, Luisi BF, Klug A. The structure of an oligo(dA).oligo(dT) tract and its biological implications. Nature 1987, 330(6145):221-226. 10.1038/330221a0, 3670410.
42. Rohs R, West SM, Sosinsky A, Liu P, Mann RS, Honig B. The role of DNA shape in protein-DNA recognition. Nature 2009, 461(7268):1248-1253. 10.1038/nature08473, 2793086, 19865164.
43. Rohs R, Jin X, West SM, Joshi R, Honig B, Mann RS. Origins of specificity in protein-DNA recognition. Annu Rev Biochem 2010, 79:233-269. 10.1146/annurev-biochem-060408-091030, 3285485, 20334529.
44. Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JE, Kuriyan J. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 1998, 93(5):827-839. 10.1016/S0092-8674(00)81443-9, 9630226.
45. Becker S, Groner B, Muller CW. Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 1998, 394(6689):145-151. 10.1038/28101, 9671298.
46. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 2004, 25(13):1605-1612. 10.1002/jcc.20084, 15264254.
47. Rouyez MC, Lestingi M, Charon M, Fichelson S, Buzyn A, Dusanter-Fourt I. IFN regulatory factor-2 cooperates with STAT1 to regulate transporter associated with antigen processing-1 promoter activity. J Immunol 2005, 174(7):3948-3958.
48. Chin YE, Kitagawa M, Kuida K, Flavell RA, Fu XY. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 1997, 17(9):5328-5337. 232383, 9271410.
49. Epling-Burnette PK, Zhong B, Bai F, Jiang K, Bailey RD, Garcia R, Jove R, Djeu JY, Loughran TP, Wei S. Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils. J Immunol 2001, 166(12):7486-7495.
50. Geller J, Petak I, Szucs KS, Nagy K, Tillman DM, Houghton JA. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin. Clin Cancer Res 2003, 9(17):6504-6515.
51. Geller JI, Szekely-Szucs K, Petak I, Doyle B, Houghton JA. P21Cip1 is a critical mediator of the cytotoxic action of thymidylate synthase inhibitors in colorectal carcinoma cells. Cancer Res 2004, 64(17):6296-6303. 10.1158/0008-5472.CAN-04-0863, 15342418.
52. Hizver J, Rozenberg H, Frolow F, Rabinovich D, Shakked Z. DNA bending by an adenine-thymine tract and its role in gene regulation. Proc Natl Acad Sci USA 2001, 98(15):8490-8495. 10.1073/pnas.151247298, 37463, 11438706.
53. Costa-Pereira AP, Tininini S, Strobl B, Alonzi T, Schlaak JF, Is'harc H, Gesualdo I, Newman SJ, Kerr IM, Poli V. Mutational switch of an IL-6 response to an interferon-gamma-like response. Proc Natl Acad Sci USA 2002, 99(12):8043-8047. 10.1073/pnas.122236099, 123017, 12060750.
54. Tanabe Y, Nishibori T, Su L, Arduini RM, Baker DP, David M. Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. J Immunol 2005, 174(2):609-613.
55. Gimeno R, Lee CK, Schindler C, Levy DE. Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes. Mol Cell Biol 2005, 25(13):5456-5465. 10.1128/MCB.25.13.5456-5465.2005, 1156979, 15964802.
56. Regis G, Pensa S, Boselli D, Novelli F, Poli V. Ups and downs: The STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling. Semin Cell Dev Biol 2008, 19(4):351-359. 10.1016/j.semcdb.2008.06.004, 18620071.
57. Schiavone D, Avalle L, Dewilde S, Poli V. The immediate early genes Fos and Egr1 become STAT1 transcriptional targets in the absence of STAT3. FEBS Lett 2011, 585(15):2455-2460. 10.1016/j.febslet.2011.06.020, 21723864.
58. Adach-Kilon A, Swiatek-Machado K, Kaminska B, Dabrowski M. Signal transducer and activator of transcription 1 (Stat1) maintains basal mRNA expression of pro-survival stat3-target genes in glioma C6 cells. J Cell Biochem 2011, 112(12):3685-3694. 10.1002/jcb.23305, 21815198.
59. Vinkemeier U, Cohen SL, Moarefi I, Chait BT, Kuriyan J, Darnell JE. DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites. Embo J 1996, 15(20):5616-5626. 452306, 8896455.
60. Yoshizawa S, Ueda T, Ishido Y, Miura K, Watanabe K, Hirao I. Nuclease resistance of an extraordinarily thermostable mini-hairpin DNA fragment, d(GCGAAGC) and its application to in vitro protein synthesis. Nucleic Acids Res 1994, 22(12):2217-2221. 10.1093/nar/22.12.2217, 523676, 8036147.
61. Hirao I, Kawai G, Yoshizawa S, Nishimura Y, Ishido Y, Watanabe K, Miura K. Most compact hairpin-turn structure exerted by a short DNA fragment, d(GCGAAGC) in solution: an extraordinarily stable structure resistant to nucleases and heat. Nucleic Acids Res 1994, 22(4):576-582. 10.1093/nar/22.4.576, 307846, 8127706.
62. Santini GP, Cognet JA, Xu D, Singarapu KK, Herve du Penhoat C. Nucleic acid folding determined by mesoscale modeling and NMR spectroscopy: solution structure of d(GCGAAAGC). J Phys Chem B 2009, 113(19):6881-6893. 10.1021/jp8100656, 19374420.